Hohl Benjamin Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
29
Insider Sells Sum
$2.37M

Insider Activity of Hohl Benjamin

According to the SEC Form 4 filings, Hohl Benjamin, being in a position of

  1. CHIEF FINANCIAL OFFICER at Enliven Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 34072 shares for $1.46M,
    over all time since 2024-01-29, has bought 0 shares, and sold 155136 shares for $4.24M.

Biography of Hohl Benjamin

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,460,2935100

Comparison of Insiders on Amount of Buys and Sells

2026-10-19SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
6,018
0.0082%
$38.48$231,546+12.89%
2026-08-17SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
6,018
0.0089%
$58.58$352,551-22.39%
2026-07-17SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
6,018
0.0083%
$52.64$316,780-0.7%
2026-06-17SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
6,018
0.0096%
$43.80$263,577+13.39%
2026-03-06SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
10,000
0.0169%
$29.58$295,839+52.38%
2025-09-29SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
3,250
0.0055%
$20.40$66,291+75.02%
2025-08-27SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
3,250
0.0055%
$20.63$67,039+36.94%
2025-07-28SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
3,250
0.0055%
$20.46$66,504+26.56%
2025-07-10SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
1,000
0.0017%
$22.66$22,655+5.22%
2025-06-27SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
3,250
0.0057%
$20.91$67,956+8.9%
2025-06-13SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
3,000
0.0063%
$22.55$67,655-0.48%
2025-05-27SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
3,250
0.0067%
$16.18$52,593+35.4%
2025-04-28SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
3,250
0.0068%
$18.69$60,738+10.79%
2025-03-27SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
3,250
0.0066%
$21.33$69,321-5.44%
2025-03-24SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
1,000
0.002%
$22.50$22,505-9.44%
2025-02-27SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
3,250
0.0067%
$20.41$66,327+0.74%
2025-02-05SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
1,000
0.0021%
$22.52$22,524-10.86%
2025-01-27SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
3,250
0.0067%
$21.59$70,178-4.74%
2025-01-03SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
1,000
0.0021%
$25.04$25,039-16.95%
2024-12-30SaleEnliven Therapeutics, Inc.
ELVN
CHIEF FINANCIAL OFFICER
900
0.0019%
$22.51$20,255-9.33%
Total: 41
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.